Td Waterhouse Canada Inc. Protalix Bio Therapeutics, Inc. Transaction History
Td Waterhouse Canada Inc.
- $12.3 Trillion
- Q3 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 6,000 shares of PLX stock, worth $10,140. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,000
Previous 6,000
-0.0%
Holding current value
$10,140
Previous $6.84 Million
8.77%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PLX
# of Institutions
49Shares Held
3.54MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$1.62 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$735,5090.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$631,6490.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$563,0580.0% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$456,3000.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $84.1M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...